Ara
Toplam kayıt 44, listelenen: 21-40
anemiler
(2021)
Genomic Spectrum and Phenotypic Heterogeneity of Human IL-21 Receptor Deficiency
(2021)
Biallelic inactivating mutations in IL21R causes a combined immunodeficiency that is often complicated by cryptosporidium
infections. While eight IL-21R-deficient patients have been reported previously, the natural course, ...
Pre-conditioning Serum Uric Acid as a Risk Factor for Sinusoidal Obstruction Syndrome of the Liver in Children Undergoing Hematopoietic Stem Cell Transplantation
(2021)
Uric acid, a known danger signal released from injured cells, is one of the valuable signs of
inflammation. We aimed to evaluate the association of serum uric acid level before the start of
conditioning regimen with the ...
Evaluation of Drug-Drug İnteractions and Their Clinical İmportance in a Pediatric Hematopoietic Stem Cell Transplantation Unit
(2021)
Background and Aims: Many drugs with narrow therapeutic range and high toxicity risk are used in hematopoietic stem cell
transplantation (HSCT) Units. The increase in the number of drugs raises the likelihood of interactions. ...
Long-Term Skin Findings İn Patients With Fanconi Anemia After Allogeneic Hematopoietic Stem Cell Transplantation
(2021)
Long-term skin findings in patients with Fanconi anemia after
allogeneic hematopoietic stem cell transplantation
Bölüm 23 (servis dersi)
(2020)
Akut lösemiler
(2020)
Seasonal Human Coronavirus Respiratory Tract Infection in Recipients of Allogeneic Hematopoietic Stem Cell Transplantation
(Oxford Univ Press, 2020)
Background. Little is known about characteristics of seasonal human coronaviruses (HCoVs) (NL63, 229E, OC43, and HKU1)
after allogeneic stem cell transplantation (allo-HSCT).
Methods. This was a collaborative Spanish and ...
Nonmyeloablative Hematopoietic Stem Cell Transplantation in a Patient with Hereditary Pulmonary Alveolar Proteinosis
(2021-02)
Nonmyeloablative hematopoietic stem cell transplantation
in a patient with hereditary pulmonary alveolar proteinosis
Hematopoietic stem cell transplantation for Wiskott-Aldrich syndrome: an EBMT Inborn Errors Working Party analysis
(2022-03)
Allogeneic hematopoietic stem cell transplantation (HSCT) is a potentially curative
treatment for patients affected by Wiskott-Aldrich syndrome (WAS). Reported HSCT
outcomes have improved over time with respect to overall ...
Thalassemia-free and graft-versus-host-free survival: outcomes of hematopoietic stem cell transplantation for thalassemia major, Turkish experience
(2022-05)
We report the national data on the outcomes of hematopoietic stem cell transplantation (HSCT) for thalassemia major (TM) patients
in Turkey on behalf of the Turkish Pediatric Stem Cell Transplantation Group. We retrospectively ...
Intestinal mycobiota composition and changes in children with thalassemia who underwent allogeneic hematopoietic stem cell transplantation
(2022-01)
Abstract
Background: Allogeneic hematopoietic stem cell transplantation (HSCT) alters the
diversity of the intestinal bacterial microbiota. This study aimed to evaluate human
mycobiota composition pre-HSCT and post-HSCT ...